Mike Foote
@mikefootemd
GI medical oncologist @MSKCancerCenter | Translational Scientist in @ldiaz1971 lab | #AnimalLover
ID: 152348715
05-06-2010 18:10:37
872 Tweet
854 Takipçi
383 Takip Edilen
Absolutely unbelievable data by Andrea Cercek Memorial Sloan Kettering Cancer Center at ASCO #ASCO2022: 100% CR rate in 14 consecutive high risk (90%+st3) rectal cancer pts w/ Dostarlimab PD1 monotherapy. NO PATIENT REQUIRED CHEMO/SURGERY/RT. #immunoablative therapy is here + published now in NEJM